Platforms Peptide
Peptide Platform
BioDuro brings together some of the strongest peptide talents across Chemistry, Biology, DMPK, Drug Substance, and Drug Product to provide an integrated platform for peptide discovery and development. By connecting multidisciplinary expertise under one roof, we help clients move efficiently from early discovery and peptide design through synthesis, characterization, biological evaluation, and development.
Broad Capabilities for Complex Peptide Programs
With more than 15,000 peptides delivered annually, BioDuro supports a broad range of peptide types and conjugates, from conventional linear and cyclic peptides to complex and highly modified molecules. Our platform combines established technologies such as SPPS and LPPS with advanced approaches including AI-enabled screening and DNA-encoded libraries (DEL). Readily available analytical assays and animal models further enable rapid characterization and in vivo evaluation.
Integrated, Customized Workflows Under One Roof
Every peptide program has unique scientific and development challenges. BioDuro offers integrated, customized workflows tailored to the needs of each program, bringing together chemistry, biology, DMPK, drug substance, and drug product capabilities. This integrated model minimizes handoffs, facilitates close scientific collaboration, and enables faster decision-making as programs progress from discovery toward development.
The Scale to Deliver, the Attention to Collaborate
BioDuro combines the resources and technical depth needed to support complex peptide programs with a high-touch, personalized service model. Our teams work closely with clients to adapt timelines, workflows, and deliverables to evolving program needs, while maintaining the speed and flexibility expected from a right-sized CRDMO partner.
One Peptide Program. Multiple Areas of Expertise.
Peptide programs often need support from more than one scientific team. A molecule may move from chemistry and optimization into biological testing, DMPK, bioanalysis, and later CMC development. At BioDuro, these teams can work together across the same program, making it easier to connect each stage as the peptide advances.
Related Resources
Explore how BioDuro combines peptide DNA-encoded libraries (DEL), AI-enabled design, high-throughput synthesis, and integrated discovery workflows to accelerate peptide drug discovery. These resources highlight platform capabilities, technology innovations, and approaches that help advance peptide programs from hit identification through candidate optimization.
Looking for a Peptide Discovery Partner?
Whether you’re exploring novel peptide modalities, validating hits, or advancing candidates toward development, BioDuro’s integrated peptide platform can help move your program forward.